Literature DB >> 14746389

Assessment of sleep and sleepiness in Parkinson disease.

Johan Marinus1, Martine Visser, Jacobus Johannes van Hilten, Gert Jan Lammers, Anne Margarethe Stiggelbout.   

Abstract

STUDY
OBJECTIVES: To develop a short and practical scale (SCOPA-SLEEP) that evaluates nighttime sleep and daytime sleepiness. The scale is developed for research in Parkinson disease but may be of value for other somatic diseases.
DESIGN: Postal survey including 4 instruments, the SCOPA-SLEEP nighttime sleep (5 items) and daytime sleepiness (6 items), the Pittsburgh Sleep Quality Index, and the Epworth Sleepiness Scale.
SETTING: Movement Disorders Center, Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. PARTICIPANTS: 143 patients with Parkinson disease and 104 controls.
INTERVENTIONS: N/A. MEASUREMENTS AND
RESULTS: Reliability of the scale was high: internal consistency of the nighttime sleep and daytime sleepiness scales were 0.88 and 0.91, respectively (Cronbach alpha), and test-retest reliabilities were 0.94 and 0.89, respectively (intraclass correlation coefficient). Scale scores differed significantly between patients and controls (P < .001). Construct validity was assessed by correlations with scales that addressed similar constructs. Correlation between the nighttime sleep scale and the Pittsburgh Sleep Quality Index was 0.83 (P < .001), and the correlation between the daytime sleepiness scale and the Epworth Sleepiness Scale was 0.81 (P < .001). Factor analysis revealed 1 factor each for both scales, indicating that the scales measure 1 construct, which justifies the calculation of sumscores. The coefficient of variation of both the nighttime sleep and the daytime sleepiness scale was higher than that of the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale, indicating a better ability to detect differences between individuals.
CONCLUSIONS: The SCOPA-SLEEP is a reliable and valid instrument for assessing nighttime sleep and daytime sleepiness in patients with Parkinson disease.

Entities:  

Mesh:

Year:  2003        PMID: 14746389     DOI: 10.1093/sleep/26.8.1049

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  54 in total

1.  Cross-cultural adaptation and psychometric properties of the SCOPA-Sleep-German version.

Authors:  Simone Goebel; Elisabeth Steinmann; Bernd Leplow; H Maximilian Mehdorn
Journal:  Neurol Sci       Date:  2018-04-14       Impact factor: 3.307

Review 2.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

3.  The major impact of freezing of gait on quality of life in Parkinson's disease.

Authors:  Courtney C Walton; James M Shine; Julie M Hall; Claire O'Callaghan; Loren Mowszowski; Moran Gilat; Jennifer Y Y Szeto; Sharon L Naismith; Simon J G Lewis
Journal:  J Neurol       Date:  2014-10-16       Impact factor: 4.849

Review 4.  Sleep disorders in multiple system atrophy.

Authors:  I Ghorayeb; B Bioulac; F Tison
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.575

Review 5.  Management of Parkinson's disease dementia : practical considerations.

Authors:  Arvid Rongve; Dag Aarsland
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson's disease and healthy controls.

Authors:  Peter Hagell; Albert Westergren; Shorena Janelidze; Oskar Hansson
Journal:  Qual Life Res       Date:  2016-05-19       Impact factor: 4.147

7.  A comprehensive model of health-related quality of life in Parkinson's disease.

Authors:  M Visser; S M van Rooden; D Verbaan; J Marinus; A M Stiggelbout; J J van Hilten
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

8.  Design and baseline characteristics of the ParkFit study, a randomized controlled trial evaluating the effectiveness of a multifaceted behavioral program to increase physical activity in Parkinson patients.

Authors:  Marlies van Nimwegen; Arlène D Speelman; Katrijn Smulders; Sebastiaan Overeem; George F Borm; Frank J G Backx; Bastiaan R Bloem; Marten Munneke
Journal:  BMC Neurol       Date:  2010-08-19       Impact factor: 2.474

Review 9.  Instruments for holistic assessment of Parkinson's disease.

Authors:  Pablo Martinez-Martin
Journal:  J Neural Transm (Vienna)       Date:  2013-03-10       Impact factor: 3.575

10.  Sleep disorders in Parkinson's disease.

Authors:  Cynthia L Comella
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.